Delivery Order SPE2DR25D2100-SPE2DR26FA1FQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,346.17 to AmerisourceBergen Drug Corp on June 7, 2025, for the supply of Prilosec DR 10 mg suspension (30 count). This competitively awarded, firm fixed price delivery order is set to be completed by June 9, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs within DLA's...
- The Defense Logistics Agency awarded a delivery order valued at $1,963.98 to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg suspension (30 count) on December 17, 2025, with an ultimate completion date of December 18, 2025. This is a firm fixed price delivery order with no set-aside designation, utilizing a competitive award process. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $11,163.12 to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg Suspension in 30-count packaging. This firm fixed-price contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Prilosec DR 2.5 mg suspension (30-count units) with a ceiling value of $1,155.57. This competitively awarded, firm fixed-price delivery order is classified as a child contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 11, 2025. No set-aside designation was utilized for this...
- The Defense Logistics Agency awarded a delivery order valued at $10,156.92 to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg suspension (30-count). This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-set-aside award executed through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Prilosec DR 10 mg suspension (30-count), a proton pump inhibitor commonly used to treat gastroesophageal reflux disease and related gastrointestinal conditions. The contract is valued at $1,626.78 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 31, 2025. This award carries no set-aside designation and was competitively...
- The Defense Logistics Agency awarded a $17,682.17 delivery order to AmerisourceBergen Drug Corp for Prilosec DR 2.5 MG Suspension (30-count), a proton pump inhibitor commonly used to treat gastroesophageal reflux disease and related gastrointestinal conditions. The contract, executed on July 21, 2025, with a completion date of July 22, 2025, employs firm fixed pricing and was competitively awarded with no set-aside designation. Performance of this delivery order occurs at the awardee's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,708.16 firm fixed-price delivery order is for the supply of Prilosec DR 10 mg suspension to support military healthcare programs. The contract has an ultimate completion date of January 15, 2025 and is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,808.82, is for the supply of Prilosec DR 10 mg suspension medication. The contract has an ultimate completion date of December 12, 2023 and is a firm fixed price delivery order. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, worth $1,050.64, is for the delivery of Prilosec DR 2.5 mg suspension medication. The contract is a Firm Fixed Price Delivery Order that will run through March 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA1FQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,636.13 to AmerisourceBergen Drug Corp for the supply of Prilosec DR 2.5 mg Suspension (30-count units). This competitive, firm fixed-price delivery order was issued on January 15, 2026, with an ultimate completion date of January 16, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating full and open competition. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and healthcare solutions provider that serves critical federal medical procurement needs for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The IDC serves as a flexible contracting instrument supporting military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 1/14/26 |